Curcumin is a long-loved ingredient, appreciated for its various human health benefits – however, challenges of bioavailability and poor absorption limit its potential.

DolCas-Tenshi Bioceuticals believe they have developed a next-generation curcumin with features that set it apart from its current competitors. Charlotte Bastiaanse, associate editor at Vitafoods Insights, talks to Dr Shavon Jackson-Michel, director of medical and scientific affairs at DolCas-Tensi Bioceuticals, about Curcugen – highlighting key features and preclinical data.